Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
========================================================================================================================

* Paul B Chapman
* Vetri Sudar Jayaprakasam
* Katherine S Panageas
* Margaret Callahan
* Michael A Postow
* Alexander N Shoushtari
* Jedd D Wolchok
* Allison Betof Warner